About the Cover
Cover image

225Ac-PSMA-617 has shown high potential to benefit patients with metastatic castration-resistant prostate cancer who are in a clinically critical situation. See page 1941.
225Ac-PSMA-617 has shown high potential to benefit patients with metastatic castration-resistant prostate cancer who are in a clinically critical situation. See page 1941.